Predictive Oncology PE Ratio 2010-2025 | POAI
Current and historical p/e ratio for Predictive Oncology (POAI) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Predictive Oncology PE ratio as of August 06, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Predictive Oncology PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-08-06 |
0.82 |
|
0.00 |
| 2025-03-31 |
1.52 |
$-1.50 |
0.00 |
| 2024-12-31 |
0.82 |
$-2.20 |
0.00 |
| 2024-09-30 |
0.79 |
$-3.05 |
0.00 |
| 2024-06-30 |
1.04 |
$-3.35 |
0.00 |
| 2024-03-31 |
2.55 |
$-3.65 |
0.00 |
| 2023-12-31 |
3.29 |
$-3.47 |
0.00 |
| 2023-09-30 |
3.20 |
$-4.62 |
0.00 |
| 2023-06-30 |
4.86 |
$-4.84 |
0.00 |
| 2023-03-31 |
6.54 |
$-6.86 |
0.00 |
| 2022-12-31 |
6.14 |
$-7.00 |
0.00 |
| 2022-09-30 |
7.20 |
$-7.60 |
0.00 |
| 2022-06-30 |
8.20 |
$-8.20 |
0.00 |
| 2022-03-31 |
19.54 |
$-6.20 |
0.00 |
| 2021-12-31 |
19.04 |
$-7.40 |
0.00 |
| 2021-09-30 |
26.60 |
$-18.20 |
0.00 |
| 2021-06-30 |
26.20 |
$-25.80 |
0.00 |
| 2021-03-31 |
24.20 |
$-32.00 |
0.00 |
| 2020-12-31 |
14.64 |
$-48.40 |
0.00 |
| 2020-09-30 |
16.28 |
$-125.80 |
0.00 |
| 2020-06-30 |
32.80 |
$-142.80 |
0.00 |
| 2020-03-31 |
31.50 |
$-131.60 |
0.00 |
| 2019-12-31 |
52.20 |
$-155.00 |
0.00 |
| 2019-09-30 |
101.00 |
$-112.20 |
0.00 |
| 2019-06-30 |
149.60 |
$-124.00 |
0.00 |
| 2019-03-31 |
150.00 |
$-168.00 |
0.00 |
| 2018-12-31 |
123.80 |
$-156.00 |
0.00 |
| 2018-09-30 |
212.00 |
$-194.00 |
0.00 |
| 2018-06-30 |
226.00 |
$-188.00 |
0.00 |
| 2018-03-31 |
220.00 |
$-230.00 |
0.00 |
| 2017-12-31 |
202.00 |
$-242.00 |
0.00 |
| 2017-09-30 |
290.80 |
$-188.00 |
0.00 |
| 2017-06-30 |
294.00 |
$-220.00 |
0.00 |
| 2017-03-31 |
420.00 |
$-338.00 |
0.00 |
| 2016-12-31 |
560.00 |
$-896.00 |
0.00 |
| 2016-09-30 |
825.00 |
$-3,314.00 |
0.00 |
| 2016-06-30 |
765.00 |
$-4,650.00 |
0.00 |
| 2016-03-31 |
865.00 |
$-6,250.00 |
0.00 |
| 2015-12-31 |
14700.00 |
$-6,000.00 |
0.00 |
| 2015-09-30 |
16070.00 |
$-3,550.00 |
0.00 |
| 2015-06-30 |
15500.00 |
$-2,150.00 |
0.00 |
| 2015-03-31 |
17250.00 |
$-350.00 |
0.00 |
| 2014-12-31 |
32500.00 |
0 |
0.00 |
| 2014-09-30 |
41250.00 |
0 |
0.00 |
| 2014-06-30 |
56250.00 |
0 |
0.00 |
| 2014-03-31 |
69375.00 |
0 |
0.00 |
| 2013-12-31 |
101250.00 |
0 |
0.00 |
| 2013-09-30 |
119250.00 |
0 |
0.00 |
| 2013-06-30 |
56250.00 |
0 |
0.00 |
| 2013-03-31 |
53250.00 |
0 |
0.00 |
| 2012-12-31 |
45000.00 |
0 |
0.00 |
| 2012-09-30 |
28125.00 |
0 |
0.00 |
| 2012-06-30 |
24375.00 |
0 |
0.00 |
| 2012-03-31 |
18750.00 |
0 |
0.00 |
| 2011-12-31 |
105000.00 |
0 |
0.00 |
| 2011-09-30 |
131250.00 |
0 |
0.00 |
| 2011-06-30 |
33750.00 |
0 |
0.00 |
| 2011-03-31 |
36000.00 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.008B |
$0.002B |
|
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|
